Drugs, Side Effects and Medical Condition

Data contains details of various drugs (used for conditions like [Acne](https://www.drugs.com/condition/acne.html), [Cancer](https://www.drugs.com/condition/malignant-disease.html), [Heart Disease](https://www.drugs.com/condition/heart-disease.html), etc. ) and their side effects

Drugs detail URLs were collected from [following dataset ](https://www.kaggle.com/datasets/jithinanievarghese/drugs-related-to-common-treatments)

Major Column Descriptors:

**generic\_name**:
The chemical name of the drug (not brand name)
**drug\_classes**:
The drug belongs to which drug class, i.e a drug class is a set of medications and other compounds that have a similar chemical structure, the same mechanism of action (i.e. binding to the same biological target), a related mode of action, and/or are used to treat the same disease.
**brand\_names**:
brand names in which the drugs are being sold or available in the market.
**activity**:
Activity is based on recent site visitor activity relative to other medications in the list. Data was gathered from https://www.drugs.com
**rx_otc**:
Rx-to-OTC switch is the transfer of proven prescription drugs to nonprescription, where
OTC (Over-the-counter) = Medication that can be purchased without a medical prescription
Rx = Prescription Needed
Rx/OTC = Prescription or Over-the-counter.

**pregnancy_category**:
A = Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B = Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C = Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D = There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X = Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N = FDA has not classified the drug.

**csa**:

Controlled Substances Act (CSA) Schedule
M = The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U = CSA Schedule is unknown.
N = Is not subject to the Controlled Substances Act.
1 = Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 = Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 = Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 = Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 = Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.

**alcohol**:
X = Interacts with Alcohol.

**rating**:
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

All other columns are self-explanatory.

**Sample Overview of dataset**


Cover Image source: https://unsplash.com/photos/nj9tmN-7YMA

本数据集包含多种药物（用于治疗诸如痤疮、癌症、心脏病等疾病）及其副作用的详细信息。

药物详情链接收集自以下数据集：（[常见治疗方法相关的药物数据集](https://www.kaggle.com/datasets/jithinanievarghese/drugs-related-to-common-treatments)）。

主要列描述如下：

**通用名称**：药物的化学名称（非品牌名称）。
**药物类别**：药物所属的药物类别，即一组具有相似化学结构、相同作用机制（即与同一生物靶标结合）、相关的作用方式，以及/或用于治疗同一疾病的药物和其他化合物。
**品牌名称**：药物在市场上销售的或可获得的品牌名称。
**活性**：基于与列表中其他药物的相对网站访问者活动。数据来自https://www.drugs.com。
**处方/非处方药转换**：处方药转换为非处方药，其中OTC（非处方药）= 无需医疗处方即可购买的药物，Rx = 需要处方。
**妊娠类别**：根据妊娠期间的动物生殖研究、人体不良反应数据以及FDA的分类，对胎儿风险进行分级。
**受控物质法案（CSA）分级**：根据受控物质法案对药物进行分级，以反映其滥用潜力。
**酒精**：表示药物与酒精的相互作用。
**评分**：用户根据药物的有效性、正面/负面效果以及使用便捷性进行评分（1 = 无效，10 = 最有效）。

所有其他列均为自解释性。

**数据集样本概述**：

[图片1](https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F6080066%2Fd876d345bf9fef8e5ac4cc7f1bb7d083%2Fdrugs_1.png?generation=1670666329679559&alt=media)
[图片2](https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F6080066%2F03424d76b09af3dee2ee08d80784c259%2Fdrugs_2.png?generation=1670666347837516&alt=media)

封面图片来源：https://unsplash.com/photos/nj9tmN-7YMA

搜集汇总

背景与挑战

背景概述

该数据集汇总了多种药物及其副作用信息，涵盖通用名、药物类别、品牌名等关键属性，并包含处方分类、妊娠安全性和受控物质等级等法规细节。数据集可用于分析药物与医疗条件（如痤疮、癌症、心脏病）的关联，以及评估用户评分和安全性指标。